Sun -
HA! That's crazy! I have never heard that term used before... so apparently... a search was needed. The FDA comes up and uses this term quite often.
FDA Guidance Documents: General and Cross-Cutting Topics
Then I found this:
Draft Definition, Prioritization Criteria, and Strategic Framework for Public Comment
The Federal Coordinating Council for Comparative Effectiveness Research (CER)
"CER investments and activities can be grouped into four major categories:
* Research, e.g., comparing medicines for a specific condition or discharge process A to discharge process B for readmissions
* Human and Scientific Capital, e.g., training new researchers to conduct CER, developing CER methodology
* CER Data Infrastructure, e.g., developing a distributed practice-based data network, linked longitudinal administrative or EHR databases, or patient registries
* Translation and Adoption of CER, e.g., building tools and methods to translate CER into practice and measure results
Furthermore, investments or activities related to a specific theme can cut across these categories. The themes are cross-cutting since they may include research, human and scientific capital, CER data infrastructure, and/or translation/adoption. These themes could include:
* Conditions, e.g., cancer
* Patient populations, e.g., the elderly, minorities, children, persons with disabilities
* Type of intervention, e.g., devices, behavioral change, delivery system"
Hmph. That's interesting. I think we learned something new today
